The endothelial nitric oxide synthase (eNOS) regulates the mobilization and function of endothelial progenitor cells (EPC). We hypothesized that eNOS of the bone marrow (BM) affects cardiac remodelling during myocardial hypertrophy via the regulation of BM-derived vascular progenitor cells.
2.1 + 0.2% in WT-TAC, P , 0.05). TAC up-regulated the number of EPCs in the peripheral blood and in the BM in WT but not in eNOS 2/2 . Baseline migratory capacity of EPCs was lower in eNOS 2/2 and was not raised by TAC in either strain. To test the role of eNOS in the BM during pressure overload, strain-mismatched (WT/ eNOS 2/2 ; eNOS 2/2 /WT) and strain-matched (WT/WT; eNOS 2/2 /eNOS 2/2 ) BM transplantations (BMTs) were 
Conclusion
eNOS of the BM plays a key role for amelioration of cardiac hypertrophy, capillary density, and fibrosis during increased afterload.
Introduction
Sustained pressure load occurring in pathological situations such as hypertension or aortic valve stenosis leads to maladaptive cardiac remodelling, which can progress to heart failure. 1, 2 Structural and functional changes of coronary microvasculature are important components of cardiac hypertrophy and fibrosis during pressure overload. 3, 4 Disruption of coordinated tissue growth and angiogenesis contributes to the transition from adaptive to maladaptive cardiac remodelling. 5, 6 Recent findings demonstrate that circulating bone marrow (BM)-derived endothelial progenitor cells (EPC) contribute to angiogenesis. 7 These cells reside within the BM and can be mobilized and stimulated to perform their functions by different physical and chemical stimuli, among which are physical exercise, body weight reduction, hormones, angiogenesis-promoting growth factors, and pharmacological agents. 8 -11 EPCs are of interest as markers to assess the prognosis of cardiovascular disease and as a potential therapeutic target. 12 Growing evidence suggests that both myocardial repair processes and EPC-mediated angiogenesis in pressure overload are depended on nitric oxide (NO) production by endothelial NO synthase (eNOS). 13 -16 However, it is not clear whether eNOS of the BM or extramedullar tissue is important for amelioration of cardiac remodelling and capillarization in increased cardiac afterload. The aim of this study was to examine the role of eNOS in the BM and the myocardium for the regulation of myocardial hypertrophy under conditions of increased cardiac afterload.
Methods

Animals and transaortic constriction
The study was approved by the animal Ethics Committee of the Universität des Saarlandes and conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Pub. No. 85-23, revised 1996). Ten-week-old male C57/Bl6 (Charles River Laboratories, Sulzfeld, Germany) and eNOS 2/2 mice (B6129/P2-Nos3, Charles River Laboratories) were housed under standard conditions. For surgery, animals were intraperitoneal anaesthetized with ketamine (100 mg/kg body weight) and xylazine (10 mg/kg). Anaesthetic monitoring was performed by testing of rear foot reflexes before and during the surgery, observation of respiratory pattern, mucous membrane colour, and responsiveness to manipulations throughout the procedure. After orotracheal intubation using a 20 G catheter, the tube was connected to a volume cycled rodent ventilator (Harvard Apparatus, Holliston, MA, USA) on supplemental oxygen with a tidal volume of 0.2 mL and a respiratory rate of 110 min 21 . The chest cavity was entered in the second intercostal space at the left upper sternal border through a small incision, and aortic constriction was performed by tying a 7-0 nylon suture ligature against a 27 G needle to yield a narrowing 360 mm in diameter and a transverse aortic constriction (TAC) of 65 -70%. Control mice underwent a sham operation. After 5 weeks, animals were intraperitoneal anaesthetized with ketamine (100 mg/kg body weight) and xylazine (10 mg/kg) and a 1.4 Fr pressure-transducing catheter (Mikro Tip Catheter, Millar instruments) was used for left ventricle (LV) pressure measurements. The adequacy of anaesthesia was evaluated as described above. After the LV pressure measurements, mice were sacrificed by intraperitoneal injection of ketamine (1 g/kg body weight) and xylazine (100 mg/kg) and hearts were rapidly excised. Hearts were partly snap frozen in liquid nitrogen and stored at 2808C and partly embedded in paraffin after fixation in PBS-buffered formalin (4%). Blood and BM were sampled, as well as the spleen for further preparation. Blood pressure was measured on the tail artery of mice 4 weeks after sham surgery or TAC on five consecutive days using at least 20 repeating measurements per day (BP 2000 Series II Blood Pressure Analysis System, Visitech Systems, NC, USA).
Bone marrow transplantation
Six-week-old C57Bl/6 wild-type (WT) mice, C57Bl/6-Tg(ACTbEGF-P)1Osb mice [Jackson Laboratory; expressing green fluorescent protein (GFP) ubiquitously], and eNOS 2/2 mice (B6129/P2-Nos3, Charles
River Laboratories) were sacrificed by intraperitoneal injection of ketamine (1 g/kg body weight) and xylazine (100 mg/kg) and marrow was obtained from the long bones. BM cells (1 -2 × 10 7 ) were transplanted into 10-week-old male, lethally irradiated (total dose 9 Gy), recipient mice by injection into the tail vein 5 h after irradiation. For this purpose, animals were anaesthetized by inhalation of 2% isoflurane and the adequacy of anaesthesia was evaluated as described above. To monitor reconstitution of the BM, three animals per group were sacrificed 4 weeks after BMT and histological examination of BM sections was performed. The detailed information is described in the Supplementary material online. Four weeks after BMT, TAC or sham operation was carried out as described above.
Fluorescence-activated cell sorter analysis
Blood and BM were analysed as described. 17 -20 The viable lymphocyte population was analysed for stem cell antigen 1 (Sca-1)-FITC (E13-161.7, Pharmingen, Germany) and vascular endothelial growth factor receptor 2 (VEGFR-2) (Flk-1; Avas12a1, Pharmingen) conjugated with the corresponding phycoerythrin-labelled secondary antibody (Sigma, Germany). Isotype-identical antibodies served as controls (Becton-Dickinson, Germany).
Culture of spleen-derived EPCs and migration assay
Spleen mononuclear cells were isolated and cultured in endothelial basal medium (Cell Systems, Germany) as described. 17 -20 Antibiotics, calf serum, and cell culture medium were obtained from Invitrogen. After 4 days in culture, 500 cells from each mouse were transferred to modified Boyden chambers (BD Bioscience, Germany) in 24-well plates filled with 750 mL medium containing 10 mL SDF-1 (R&D Systems, Germany) to assess their migratory capacity. After 24 h of incubation, tetramethylindocarbocyanine-labelled acetylated low-density lipoprotein (DiLDL, 2.4 mg/ mL; Cell Systems) was added to identify EPCs. Boyden chamber filters were cut out, placed on slides, and mounted with fluorescent mounting medium (Vectashield, Vector Laboratories, Burlingame, CA, USA) for fluorescence microscopic analysis. The whole filter was analysed using a Nikon E600 epifluorescence microscope (Nikon, Japan) with appropriate filters. Cells positive for red DiI-Ac-LDL were judged to be EPCs and were counted.
Immunofluorescence analysis
To detect cardiomyocytes, capillaries, cycling cardiomyocytes, endothelial cells, fibroblasts, and GFP immunostainings on 3 mm paraffin sections of the LV were performed using heat-mediated antigen retrieval with citraconic anhydride solution followed by overnight incubation at 48C with the first antibody and incubation with the appropriate secondary antibody at 378C for 1 h. The detailed methods are described in the Supplementary material online.
Tissue morphometry
For morphometric analyses, LV tissue sections (3 mm) were examined. Numbers of cross-sectioned capillary and cardiomyocyte profiles (all cross-sectioned muscle fibres with and without nuclei) per mm 2 were determined in tissue sections double stained for podocalyxin and a-sarcomeric actin in 20 randomly chosen fields at ×1000 magnification. Two sections per each heart were analysed. Capillary density and the ratio of capillaries to cardiomyocytes were calculated. The cardiomyocyte short-axis diameter and the degree of cardiac fibrosis were evaluated as described. (Figure 2A and B).
Boyden chamber assays showed that EPC of eNOS 2/2 mice were characterized by a markedly lower migratory capacity compared with WT mice, and migration of the WT EPC was two-fold higher than the eNOS 2/2 EPC ( Figure 2C ). TAC reduced migratory capacity of WT EPC but the effect was not significant; TAC had no effect on the migration of eNOS 2/2 EPC ( Figure 2C ). The capillary density was higher in eNOS 2/2 mice and the ratio of capillaries to cardiomyocytes was similar in eNOS 2/2 and WT mice ( Figure 2D and E). eNOS and EPC-mediated neoangiogenesis
Strain-mismatched transplantations: importance of eNOS in the BM for myocardial remodelling and fibrosis
To assess the importance of eNOS in the BM for cardiac remodelling, both WT mice and eNOS 2/2 mice were transplanted with WT or eNOS 2/2 BM. These four groups were randomized to sham surgery or aortic ligation. Similar to the results of the mice without BM transplantation (BMT), aortic banding caused an elevation of LVSP, LVEDP, and dP/dt max that was significantly higher in all eNOS 2/2 mice compared with WT, and these findings were not affected by the strain-mismatched BMT ( Table 1) . Strain-mismatched transplantation of eNOS 2/2 BM increased and of WT BM decreased the ratio of lung fluid weight to tibia length in TAC groups, pointing out a negative effect of eNOS 2/2 BM for this symptom of heart failure ( Table 1) . Aortic constriction increased the ratio of heart weight to tibia length in all groups of the BM transplanted animals. However, WT mice that received eNOS 2/2 BM showed increased cardiac hypertrophy compared with the other TAC groups ( Table 1) . Cardiac fibrosis was increased by TAC in all BM transplanted animals. Strainmismatched transplantation of eNOS 2/2 BM into WT dramatically increased the extent of fibrosis which was increased by four-fold post-TAC surgery ( Figure 3A) . BM ( Figures 3A and 4A) . Taken together, these data show the importance of eNOS in BM cells for myocardial fibrosis. There were no significant differences between the groups with regard to the percentages of proliferating cardiomyocytes and noncardiomyocytes A. Kazakov et al.
3.5 Decreased EPC and reduced capillary density in mice lacking eNOS in the BM eNOS 2/2 mice transplanted with WT BM showed a marked increase in the numbers of EPC circulating in the blood and of the EPC in the BM ( Figure 3B and C ) . TAC enhanced the number of EPCs in the blood and in the BM in WT/WT/TAC but did not increase EPC in mice that were deficient of eNOS either in the periphery or in the BM ( Figure 3B and C ). Both TAC and sham mice lacking eNOS in the BM showed a reduced migratory capacity compared with mice with WT BM. Aortic constriction reduced migratory capacity in all groups with the exception of eNOS 2/2 /eNOS 2/2 /TAC ( Figure 3D ).
Mice lacking eNOS 2/2 both in the BM and in the extramedullary tissues showed reduced capillary density and a reduced ratio of capillaries to cardiomyocytes compared with corresponding WT/WT controls. Strain-mismatched transplantation of eNOS 2/2 BM worsened both parameters in the TAC group. In contrast, transplantation of WT BM in eNOS 2/2 mice significantly ameliorated capillarization of the LV in both sham-and TAC-operated animals compared with corresponding eNOS 2/2 /eNOS 2/2 groups. Capillary density and the ratio of capillaries to cardiomyocytes in pressure-overloaded myocardium were significantly diminished in all groups with the exception of eNOS 2/2 /WT/TAC compared with corresponding SHAM groups ( Figures 3E and F, and 4B) . Transplantation of GFP-positive BM cells was used to study the importance of extramedullar eNOS for the integration and transdifferentiation of BM-derived cells in the pressure-overloaded heart. Both chimeric mice had eNOS in their BM since the transplanted GFP-positive BM contained eNOS. Aortic banding increased the percentage of podocalyxin pos GFP pos cells in the LV myocardium of both chimeric groups compared with sham ( Figure 5 , WT/GFP/sham 2.5 + 0.6%, WT/GFP/TAC 13 + 3.4%, P , 0.05; eNOS 2/2 /GFP/sham 4.8 + 1.6%, eNOS 2/2 /GFP/TAC 14.6 + 3.5%, P , 0.05). In some animals from the WT/GFP/TAC group, large cardiomyocytes co-staining with a-sarcomeric actin and GFP were found.
Discussion
The main finding of the study is the importance of eNOS of the BM for cardiac remodelling during increased cardiac afterload. Pressure overload by TAC up-regulated the number of BM-derived progenitor cells in the peripheral blood and in the BM in WT but not in eNOS 24 Moreover, amelioration of cardiac remodelling by exercise training depends on the level of eNOS in the cardiovascular system. 25 -27 Here, we extend these findings with the observation that eNOS of the BM plays a central role during myocardial remodelling in increased cardiac afterload. Aortic ligation for 5 weeks led to significant elevation of LV systolic and end-diastolic pressures in both strains, more pronounced in eNOS 2/2 animals where these parameters were increased also in the sham-operated group. TAC induced myocardial and cardiomyocyte hypertrophy, elicited cardiac fibrosis, and stimulated proliferation of cardiomyocytes and non-cardiomyocytes in eNOS 2/2 and WT mice. The absence of eNOS did not increase the number of cycling cells in the pressure-overloaded LV. The most prominent effect of systemic eNOS deficiency was the marked increase in myocardial fibrosis compared with WT animals. The increase in cardiac fibrosis in the eNOS 2/2 is consistent with induction of endothelial-mesenchymal transformation, activation of matrix metalloproteinases causing remodelling of extracellular matrix, and loss of endothelial cells. 28 -30 To specifically investigate the role of eNOS in the BM for cardiac remodelling and capillarization during increased cardiac afterload and to exclude the compensatory angiogenic mechanisms in the myocardium, BMTs were performed. In strain-matched BM transplanted animals, cardiac fibrosis was more pronounced in eNOS 2/2 / eNOS 2/2 /TAC mice. Aortic banding reduced myocardial capillarization in eNOS 2/2 /eNOS 2/2 /TAC compared with WT/WT/TAC.
This reduction is likely due to an enhancement of the anti-angiogenic effects of eNOS-deficiency by ionizing radiation accelerating senescence of mouse tissues. 31, 32 Strain-mismatched transplantation of WT BM reduced pulmonary congestion and ameliorated cardiac fibrosis and capillarization, despite increased LV systolic and enddiastolic pressures in aortic-ligated mice. This ameliorative effect of WT BM on cardiac remodelling was observed parallel to the augmented myocardial angiogenesis associated with high levels of EPCs in the BM and in the peripheral blood and their increased migratory activity. In contrast, aortic-ligated WT mice lacking eNOS in the BM demonstrated marked pulmonary congestion, increased cardiac hypertrophy and fibrosis, reduced myocardial capillarization, diminished levels of Figure 4 Effects of eNOS deficiency in the BM and extramedullar eNOS deficiency for cardiac fibrosis and capillary density. Representative sections of the LV myocardium stained with picrosirius red (A) and co-immunostaining for myocytic a-sarcomeric actin (green) and the capillary marker podocalyxin (red) (B). Bars ¼ 30 mm.
eNOS and EPC-mediated neoangiogenesis
EPCs in the peripheral blood and in the BM, and deteriorated EPC migration. The presence of EPC mobilization only in WT/WT/TAC mice and reduction in their migratory capacity by TAC demonstrate the importance of eNOS both in the EPCs and in the local microenvironment of the BM for EPC mobilization and maintenance of their functions in pressure overload. 21 Thus, eNOS in EPCs and BM is important for cardiac angiogenesis during pressure overload. Moreover, reduced cardiac fibrosis associated with increased myocardial capillarization in aortic-ligated eNOS 2/2 mice supplemented with eNOSpositive BM compared with eNOS 2/2 /eNOS 2/2 /TAC and WT/ eNOS 2/2 /TAC demonstrates the key role of eNOS in the BM-derived endothelial cells but not in cardiomyocyte for its reduction in pressure overload. 16 Thus, beneficial effects of eNOS during cardiac remodelling depend not only on the availability of eNOS in the cardiovascular system but also on intact eNOS activity in the BM. This may be of importance during interventions that increase eNOS activity such as physical exercise. Indeed, the effects of exercise training in pathological hypertrophy and dysfunction may depend on intact eNOS activity in BM-derived cells. 25 -27 This concept of BM-derived cells contributing to myocardial remodelling was further supported by results of experiments with transplantation of GFP-positive BM cells in WT and eNOS 2/2 animals.
Congenital eNOS deficiency in extramedullar tissues did not influence the number of BM-derived endothelial podocalyxin pos GFP pos cells in the myocardium showing that renewal of chronic dysfunctional cardiac endothelium is primarily mediated by resident cardiac stem cells and proliferation of mature endothelial cells. 33 In contrast, the number of podocalyxin pos GFP pos cells was similarly elevated in the myocardium of both strains under conditions of increased cardiac afterload, demonstrating the importance of medullary eNOS for the integration of BM-derived cells in the pressure-overloaded heart. In summary, the data show that the BM is an important organ participating in the regulation of myocardial remodelling. Specifically, eNOS in the BM was identified as a regulator of myocardial angiogenesis and fibrosis in pressure-induced cardiac hypertrophy. This finding may lead to intriguing perspectives for the development of novel treatment strategies of pressure-induced cardiac hypertrophy and enhancing of myocardial capillarization to eventually delay transition to maladaptive cardiac remodelling.
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Supplementary material is available at Cardiovascular Research online.
